Drugs / Phentholamine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT00955929 | Aug 2009 → Dec 2020 | erectile dysfunction, penile cancer | Memorial Sloan Kettering Cancer Center | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Phentholamine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00955929 ↗ |
| Route | Other | “Intracavernous injections of a trimix combination (Papaverine 30mg/mL Phentholamine 1mg/mL Prostaglandin E1 10 mcg/mL)” NCT00955929 ↗ |